Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
fatty acid (1 trial)
rosuvastatin (crestor) (1 trial)
valsartan (diovan) (1 trial)
Atrial Fibrillation (Phase 3)
Heart Failure (Phase 3)
Recurrence (Phase 3)
Trials (2 total)
Trial APIs (3 total)